Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis

Prostaglandin E2 (PGE2) has been known to modulate immune responses by inhibiting T-cell activation following hemorrhagic and traumatic injury. Recently, we documented a sepsis-related depression in concanavalin A (ConA)-induced T-cell proliferation and intracellular Ca2+ (Ca2+i) mobilization. The present study evaluated the potential role of PGE2 in the sepsis-related attenuation in Ca2+ signaling and proliferation in T cells. Sepsis was induced in rats by implanting into their abdomen fecal pellets containing Escherichia coli (150 CFU) and Bacteroides fragilis (10(4) CFU). A group of rats implanted with septic pellets were treated with indomethacin at three consecutive time points. Levels of PGE2 in blood were measured with a radioimmunoassay kit. ConA-induced [Ca2+]i mobilization in T cells obtained from indomethacin-treated and untreated rats was measured with Fura-2 and microfluorometry. We observed a 10-fold increase in PGE2 levels in the circulation of septic rats compared with levels in rats implanted with bacterium-free sterilized pellets. The proliferative response and Ca2+i mobilization were significantly depressed in T cells obtained from septic rats 48 h after implantations compared with those in rats implanted with sterile pellets. However, treatment of rats with the cyclooxygenase inhibitor indomethacin prevented the sepsis-related depression in ConA-induced T-cell Ca2+i mobilization as well as proliferation. Further, incubation of T cells from nonimplanted control rats with PGE2 resulted in a substantial depression in both T-cell proliferation and Ca2+i mobilization. The restoration of T-cell proliferation and Ca2+ signaling after indomethacin treatment of septic rats and the depression in the mitogen responsiveness in T cells previously exposed to PGE2 suggest that the PGE2 does play a significant role in the modulation of T-cell responses in septic rats and that such PGE2-induced suppression in T-cell activation is likely due to an attenuation in Ca2+ signaling.

[1]  T. Roszman,et al.  Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. , 1994, Cellular immunology.

[2]  D. Hoyt,et al.  EFFECTS OF TRAUMA ON IMMUNE CELL FUNCTION: IMPAIRMENT OF INTRACELLULAR CALCIUM SIGNALING , 1994, Shock.

[3]  D. Chen,et al.  Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles , 1994, The Journal of experimental medicine.

[4]  Y. Chancerelle,et al.  Restoration of postburn impaired lymphocyte responsiveness by nonsteroidal anti‐inflammatory drugs is independent of prostaglandin E2 inhibition , 1994, Journal of leukocyte biology.

[5]  K. Thompson,et al.  Skeletal muscle Ca2+ flux and catabolic response during sepsis. , 1993, The American journal of physiology.

[6]  P. Lipsky,et al.  Anti-CD3-stimulated Ca2+ signal in individual human peripheral T cells. Activation correlates with a sustained increase in intracellular Ca2+1. , 1993, Journal of immunology.

[7]  F. Schildberg,et al.  Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. , 1993, The Journal of trauma.

[8]  R. Coffman,et al.  Cytokine regulation of T-cell function: potential for therapeutic intervention. , 1993, Trends in pharmacological sciences.

[9]  I. Chaudry,et al.  Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. , 1992, The Journal of surgical research.

[10]  G. Bottoms,et al.  Involvement of prostaglandins and leukotrienes in the pathogenesis of endotoxemia and sepsis. , 1992, Journal of the American Veterinary Medical Association.

[11]  F. Paliogianni,et al.  Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. , 1992, Journal of immunology.

[12]  J. Mannick,et al.  The role of prostaglandin E2 in immune suppression following injury. , 1991, Annals of surgery.

[13]  L. Davis,et al.  Delineation of the mechanism of inhibition of human T cell activation by PGE2. , 1990, Journal of immunology.

[14]  E. Gelfand,et al.  Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation. , 1990, Journal of immunology.

[15]  B. Huber,et al.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation , 1990, The Journal of experimental medicine.

[16]  T. Mustelin,et al.  T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. , 1990, Science.

[17]  G. Crabtree.  Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.

[18]  A. López-Rivas,et al.  Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells , 1988, European journal of immunology.

[19]  I. Chaudry,et al.  Prostaglandin E2 depresses antigen-presenting cell function of peritoneal macrophages. , 1988, The Journal of surgical research.

[20]  R. Miller,et al.  Cyclic AMP concentrations modulate both calcium flux and hydrolysis of phosphatidylinositol phosphates in mouse T lymphocytes. , 1988, Journal of immunology.

[21]  E. Faist,et al.  Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. , 1987, The Journal of trauma.

[22]  K. Welte,et al.  Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate. , 1987, The Journal of clinical investigation.

[23]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[24]  J. Ninnemann,et al.  Participation of prostaglandin E in immunosuppression following thermal injury. , 1984, The Journal of trauma.

[25]  S. Calvano,et al.  Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, interleukin 2, and a prostaglandin inhibitor, WY-18251. , 1984, Clinical immunology and immunopathology.

[26]  J. Hansbrough,et al.  Postburn immunosuppression in an animal model: monocyte dysfunction induced by burned tissue. , 1983, Surgery.

[27]  I. Saporoschetz,et al.  Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. , 1982, Archives of surgery.

[28]  R. Tsien,et al.  T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes , 1982, Nature.

[29]  A. Munck,et al.  Prostaglandin inhibition of T-cell proliferation is mediated at two levels. , 1981, Cellular immunology.

[30]  D. Fabian.  Prostaglandins in human burn wound secretion , 1978 .

[31]  R. Messner,et al.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell , 1977, The Journal of experimental medicine.

[32]  Elizabeth Simpson,et al.  A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.

[33]  D. Ballantyne,et al.  Altered Reactivity to Skin Homografts in Severe Thermal Injury , 1964, Annals of surgery.

[34]  M. Choudhry,et al.  T-lymphocyte Ca2+ signalling and proliferative responses during sepsis. , 1994, Shock.

[35]  M. Choudhry,et al.  Sepsis-induced myofibrillar protein catabolism in rat skeletal muscle. , 1994, Life sciences.

[36]  T. Mustelin,et al.  Molecular events mediating T cell activation. , 1990, Advances in immunology.

[37]  G. Crabtree,et al.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.

[38]  D. Inthorn,et al.  Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. , 1990, The Journal of trauma.

[39]  G. Kammer.  The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. , 1988, Immunology today.

[40]  R. Falk,et al.  Prostaglandin E-related impaired expression of interleukin-2 receptor in the burn patient. , 1987, Advances in prostaglandin, thromboxane, and leukotriene research.

[41]  J. Hansbrough,et al.  Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs. , 1984, Surgery.